Dolo-650 bribery allegation: Why pharma cos need tight monitoring
Dolo-650 manufacturer struck gold during the pandemic; was raided by IT in July, accusing it of bribing doctors through ₹1,000 crore “freebies” to push drug sale during the pandemic
dolo 650
October 2022
August 2022
February 2022
DOLO freebies: SC asks Centre’s reply on price control mechanism
NGO FMRAI tells SC that DOLO drug maker distributed freebies worth ₹1,000 crore to doctors for prescribing its 650 mg dosages
Covid-19 effect: Dolo, Augmentin top selling medicines in Jan
Dolo saw a 210% growth while Augmentin 62% in January 2022 as against the same month last year.
